Showing results (1-10 of 161) with videos related to
Sort By:
Pageof 17
Annals of the New York Academy of Sciences|December 13, 2005
Combined therapy with deferoxamine and deferiproneAntonis KattamisEuropean Journal of Haematology|June 16, 2018
Optimising management of deferasirox therapy for patients with transfusion-dependent thalassaemia and lower-risk myelodysplastic syndromesAntonis Kattamis, Yesim Aydinok, Ali TaherBritish Journal of Haematology|March 21, 2014
Current approach to iron chelation in childrenYesim Aydinok, Antonis Kattamis, Vip ViprakasitLancet (London, England)|June 12, 2022
ThalassaemiaAntonis Kattamis, Janet L Kwiatkowski, Yesim AydinokFrontiers in Oncology|June 5, 2023
Telomere biology: from disorders to hematological diseasesKleoniki Roka, Elena E Solomou, Antonis KattamisBritish Journal of Haematology|October 19, 2010
Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermediaVassilis Ladis, Helen Berdousi, Efstathios Gotsis, et al.International Journal of Paediatric Dentistry|March 24, 2021
Dental late effects of antineoplastic treatment on childhood cancer survivors: Radiographic findingsKyriaki Seremidi, Katerina Kavvadia, Antonis Kattamis, et al.International Journal of Laboratory Hematology|May 5, 2026
Iron Overload: Pathophysiology, Diagnosis and MonitoringElena Chatzikalil, Polyxeni Delaporta, Konstantinos Bistas, et al.Postgraduate Medical Journal|August 28, 2024
Telomere biology disorders: from dyskeratosis congenita and beyondKleoniki Roka, Elena Solomou, Antonis Kattamis, et al.Annals of Hematology|January 27, 2019
Antibody persistence 5 years after a 13-valent pneumococcal conjugate vaccine in asplenic patients with β-thalassemia: assessing the need for boosterIoanna Papadatou, Theano Lagousi, Antonis Kattamis, et al.Pageof 17